Download PDF
Klin Padiatr 2013; 225(04): 191-192
DOI: 10.1055/s-0033-1349119
Editorial
© Georg Thieme Verlag KG Stuttgart · New York

Future Developments of Clinical Research in Pediatrics: The Role of the Journal Klinische Pädiatrie

Zukünftige Entwicklungen der klinischen Forschung in der Pädiatrie: Die Rolle der Zeitschrift Klinischen Pädiatrie
D. Körholz
,
L. Gortner
,
U. Göbel
Further Information

Publication History

Publication Date:
31 July 2013 (online)

Also available at
   Permissions and Reprints

Recently, in German a new law – “Patientenrechtegesetz” §630aBGBff – was signed by the government to strengthen patients’ rights providing best care. A prerequisite for best care are conclusive information on diagnostics, treatment and prognosis. Thus, the relevance of clinical trials and clinical registries providing sufficient data for evidence-based medicine will increase during the next years. Therefore appropriate generating of the studies hypothesis, sample size calculations and study management apart from project funding as well as rapid information of the respective scientific community are of crucial importance. The lack of clinical evidence from Cochrane analyses in neonatology and other fields from pediatrics underlines this statement [12] [13.]

 

  • References

  • 1 Conroy S, McIntyre J. The use of unlicensed and off-label medicines in the neonate. Semin Fetal Neonatal Med 2005; 10: 115-122
    CrossrefPubMedGoogle Scholar
  • 2 Crandall W, Kappelman MD, Colletti RB et al. ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network. Inflamm Bowel Dis 2011; 17: 450-457
    CrossrefPubMedGoogle Scholar
  • 3 Fulda S. Molecular Targeted therapies for rhabdomyosarcoma: Focus on hedgehog and apoptosis signaling. Klin Padiatr 2013; Apr 26. [Epub ahead of print]
    PubMedGoogle Scholar
  • 4 Gathmann B, Grimbacher B, Kindle G et al. The German National Registry for Primary Immunodeficiencies (PID). Clin Exp Immunol 2013; Mar 15. DOI: 10.1111/cei.12105. [Epub ahead of print]
    PubMedGoogle Scholar
  • 5 Göbel U, Gortner L. The impact factor is volatile and sensitive. Klin Padiatr 2012; 224: 285-290
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Göbel U, Heinrich B, Krauth KA et al. Process and outcome quality of the German Paediatric Surveillance Unit. Klin Padiatr 2010; 222: 92-97
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Göpel W, Kribs A, Ziegler A et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011; 378: 1627-1634
    CrossrefPubMedGoogle Scholar
  • 8 Grunewald TG, Greulich N, Kontny U et al. Targeted therapeutics in treatment of children and young adults with solid tumors: an expert survey and review of the literature. Klin Padiatr 2012; 224: 124-131
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Harari S, Cottin V, Humbert M. Gobal effort against rare and orphan disease. Eur Respir Rev 2012; 21: 171-172
    CrossrefPubMedGoogle Scholar
  • 10 Krudewig J, Baumann U, Bernuth von H et al. Arbeitsgemeinschaft Pädiatrische Immunologie e. V. (API). Interdisciplinary AWMF guideline for the treatment of primary antibody deficiencies. Klin Padiatr 2012; 224: 404-415
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Masoodi I, Alsayari K, Albishri J. Inflammatory bowel disease register: Steps towards Crohn’s & colitis foundation of Saudi Arabia (CCFSA). Int J Health Sci (Qassim) 2012; 6: 232-236
    PubMedGoogle Scholar
  • 12 Meyer S, Willhelm C, Girisch W et al. The role of developing countries in generating Cochrane meta-analyses in the field of pediatrics (neo­natology and neuropediatrics): a systematic analysis. World Health Popul 2013; 14: 24-32
    PubMedGoogle Scholar
  • 13 Meyer S, Schroeder N, Willhelm C et al. Clinical recommendations of Cochrane reviews in 3 different fields of paediatrics (Neonatology, neuropaediatrics, and complementary and alternative medicine): A systematic analysis. Pediatr Int 2013; Apr 8 DOI: 10.1111/ped.12109. [Epub ahead of print]
    PubMedGoogle Scholar
  • 14 Minden K, Klotsche J, Niewerth M et al. Biologics register JuMBO: Long-term safety of biologic therapy of juvenile idiopathic arthritis. Z Rheumatol 2013; 72: 339-346
    CrossrefPubMedGoogle Scholar
  • 15 Nguyen KA, Claris O, Kassai B. Unlicensed and off-label drug use in a neonatal unit in France. Acta Paediatr 2011; 100: 615-617
    CrossrefPubMedGoogle Scholar
  • 16 Neubert J, Niehues T, Baumann U et al. Leitlinie der Pädiatrische Arbeitsgemeinschaft AIDS (PAAD) e.V. zur antiretroviralen Therapie bei HIV-infizierten Kindern und Jugendlichen. Klin Padiatr 2012; 224: 98-110
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Schultze-Florey RE, Graf N, Vorwerk P et al. DICER1 Syndrome: A new cancer syndrome. Klin Padiatr 2013; Apr 26. [Epub ahead of print]
    PubMedGoogle Scholar
  • 18 Stichtenoth G, Demmert M, Bohnhorst B et al. Major contributors to hospital mortality in very-low-birth-weight infants: data of the birth year 2010 cohort of the German Neonatal Network. Klin Padiatr 2012; 224: 276-281
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Witt O, Milde T, Deubzer HE et al. Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma or leukemia. Klin Padiatr 2012; 224: 398-403
    Article in Thieme ConnectPubMedGoogle Scholar